Shanghai Model Organisms Center, Inc. (SHA:688265)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Standardized Model	203.02M	164.77M			94.91M	53.44M	-
Standardized Model Growth	23.22%	-			77.59%	-	-
Custom Model	33.32M	33.91M			38.11M	42.48M	-
Custom Model Growth	-1.73%	-			-10.28%	-	-
Drug Efficacy Evaluation and Phenotypic Analysis	58.87M	53.20M			38.15M	18.08M	-
Drug Efficacy Evaluation and Phenotypic Analysis Growth	10.64%	-			111.06%	-	-
Model Breeding	80.04M	90.06M			74.85M	56.82M	-
Model Breeding Growth	-11.13%	-			31.72%	-	-
Feeding Service	36.35M	29.97M			24.98M	22.40M	-
Feeding Service Growth	21.32%	-			11.51%	-	-
Other Model Biotechnology Services	6.69M	6.58M			2.63M	2.34M	-
Other Model Biotechnology Services Growth	1.71%	-			12.56%	-	-
Biotechnology	-	-			-	-	154.80M
Biotechnology Growth	-	-			-	-	27.47%
Total	418.29M	378.49M			273.64M	195.56M	154.80M
Total Growth	10.52%	-			39.92%	26.33%	27.47%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	359.90M	-			-	-	154.80M
China Growth	-	-			-	-	27.47%
Overseas	58.39M	-			-	-	-
Total	418.29M	-			-	-	154.80M
Total Growth	-	-			-	-	27.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error